UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
<Ingredient xmlns="http://hl7.org/fhir">
<id value="TPTDteva-2080-Solution-SE-IS-ING"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLIngredient"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: Ingredient TPTDteva-2080-Solution-SE-IS-ING</b></p><a name="TPTDteva-2080-Solution-SE-IS-ING"> </a><a name="hcTPTDteva-2080-Solution-SE-IS-ING"> </a><a name="hcTPTDteva-2080-Solution-SE-IS-ING-en-US"> </a><p><b>status</b>: Active</p><p><b>for</b>: </p><ul><li><a href="MedicinalProductDefinition-TPTDteva-2080-Solution-SE-IS-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001594-00053004,http://ema.europa.eu/fhir/eurdId#2903; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Solution for injection in pre-filled pen; indication = Teriparatide Teva är avsett för vuxna. Behandling av osteoporos hos postmenopausala kvinnor och hos män med ökad risk för frakturer (se avsnitt 5.1). Incidensen vertebrala och icke-vertebrala frakturer reduceras signifikant hos postmenopausala kvinnor men detta har ej visats för höftfrakturer. Behandling av osteoporos i samband med kronisk systemisk glukokortikoidbehandling hos kvinnor och män med ökad risk för frakturer (se avsnitt 5.1).; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = H05AA02</a></li><li><a href="ManufacturedItemDefinition-TPTDteva-2080-Solution-SE-IS-MID.html">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Solution for injection in pre-filled pen; unitOfPresentation = Pen</a></li><li><a href="AdministrableProductDefinition-TPTDteva-2080-Solution-SE-IS-APD.html">AdministrableProductDefinition: status = active; administrableDoseForm = Solution for injection</a></li></ul><p><b>role</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072050 100000072072}">Active</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000089193}">Teriparatide</span></td></tr></table><blockquote><p><b>strength</b></p><p><b>concentration</b>: 0.25 milligram(s)<span style="background: LightGoldenRodYellow"> (Details: 100000110633 code100000110655 = '100000110655')</span>/1 milliliter(s)<span style="background: LightGoldenRodYellow"> (Details: 100000110633 code100000110662 = '100000110662')</span></p><blockquote><p><b>referenceStrength</b></p><h3>Substances</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000089193}">Teriparatide</span></td></tr></table><p><b>strength</b>: 0.25 milligram(s)<span style="background: LightGoldenRodYellow"> (Details: 100000110633 code100000110655 = '100000110655')</span>/1 milliliter(s)<span style="background: LightGoldenRodYellow"> (Details: 100000110633 code100000110662 = '100000110662')</span></p></blockquote></blockquote></blockquote></div>
</text>
<status value="active"/>
<for>🔗
<reference
value="MedicinalProductDefinition/TPTDteva-2080-Solution-SE-IS-MPD"/>
</for>
<for>🔗
<reference
value="ManufacturedItemDefinition/TPTDteva-2080-Solution-SE-IS-MID"/>
</for>
<for>🔗
<reference
value="AdministrableProductDefinition/TPTDteva-2080-Solution-SE-IS-APD"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000072050"/>
<code value="100000072072"/>
<display value="Active"/>
</coding>
</role>
<substance>
<code>
<concept>
<coding>
<system
value="https://spor.azure-api.net/sms/api/v2/SubstanceDefinition"/>
<code value="100000089193"/>
<display value="Teriparatide"/>
</coding>
</concept>
</code>
<strength>
<concentrationRatio>
<numerator>
<value value="0.25"/>
<unit value="milligram(s)"/>
<system value="http://spor.ema.europa.eu/v1/lists/100000110633"/>
<code value="100000110655"/>
</numerator>
<denominator>
<value value="1"/>
<unit value="milliliter(s)"/>
<system value="http://spor.ema.europa.eu/v1/lists/100000110633"/>
<code value="100000110662"/>
</denominator>
</concentrationRatio>
<referenceStrength>
<substance>
<concept>
<coding>
<system
value="https://spor.azure-api.net/sms/api/v2/SubstanceDefinition"/>
<code value="100000089193"/>
<display value="Teriparatide"/>
</coding>
</concept>
</substance>
<strengthRatio>
<numerator>
<value value="0.25"/>
<unit value="milligram(s)"/>
<system value="http://spor.ema.europa.eu/v1/lists/100000110633"/>
<code value="100000110655"/>
</numerator>
<denominator>
<value value="1"/>
<unit value="milliliter(s)"/>
<system value="http://spor.ema.europa.eu/v1/lists/100000110633"/>
<code value="100000110662"/>
</denominator>
</strengthRatio>
</referenceStrength>
</strength>
</substance>
</Ingredient>